Global Circulating Tumor Cells Sales Market Report 2023

Publication ID:

PB501231854

Publication Date:

January 2, 2023

Pages:

133

Publisher:

MRRPB5

Countries:

Global [1]

USD 4,000.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of these markers in monitoring disease progression and potentially guiding personalized cancer therapy.
Market Analysis and Insights: Global Circulating Tumor Cells Market
Due to the COVID-19 pandemic, the global Circulating Tumor Cells market size is estimated to be worth US$ 1584.6 million in 2022 and is forecast to a readjusted size of US$ 5895.4 million by 2029 with a CAGR of 20.4% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, CTC Enrichment accounting for % of the Circulating Tumor Cells global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Breast Cancer segment is altered to an % CAGR throughout this forecast period.
Global Circulating Tumor Cells main players are Menarini-Silicon Biosystems, Qiagen锛圓dnagen锛�, Clearbridge Biomedics, Celsee, Fluidigm. Global top five manufacturers hold a share over 30%.
Global Circulating Tumor Cells Scope and Market Size
The global Circulating Tumor Cells market is segmented by company, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Circulating Tumor Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2018-2029.
Segment by Type
CTC Enrichment
CTC Detection
CTC Analysis
Segment by Application
Breast Cancer
Prostate Cancer
Colorectal Cancer
Lung Cancer
Others
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Circulating Tumor Cells Market Size by Type (2018 VS 2022 VS 2029)
1.2.2 CTC Enrichment
1.2.3 CTC Detection
1.2.4 CTC Analysis
1.3 Market by Application
1.3.1 Global Circulating Tumor Cells Market Share by Application (2018 VS 2022 VS 2029)
1.3.2 Breast Cancer
1.3.3 Prostate Cancer
1.3.4 Colorectal Cancer
1.3.5 Lung Cancer
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Circulating Tumor Cells Market Perspective (2018-2029)
2.2 Global Circulating Tumor Cells Market Size by Region: 2018 VS 2022 VS 2029
2.3 Global Circulating Tumor Cells Revenue Market Share by Region (2018-2023)
2.4 Global Circulating Tumor Cells Revenue Forecast by Region (2024-2029)
2.5 Geographic Market Analysis: Market Facts & Figures
2.5.1 United States Circulating Tumor Cells Estimates and Projections (2018-2029)
2.5.2 Europe Circulating Tumor Cells Estimates and Projections (2018-2029)
2.5.3 China Circulating Tumor Cells Estimates and Projections (2018-2029)
2.5.4 Japan Circulating Tumor Cells Estimates and Projections (2018-2029)
2.5.5 Southeast Asia Circulating Tumor Cells Estimates and Projections (2018-2029)
2.5.6 India Circulating Tumor Cells Estimates and Projections (2018-2029)
3 Global Circulating Tumor Cells Competition Landscape by Players
3.1 Global Top Circulating Tumor Cells Players by Revenue (2018-2023)
3.1.1 Global Top Circulating Tumor Cells Players by Revenue (2018-2023)
3.1.2 Global Circulating Tumor Cells Revenue Market Share by Players (2018-2023)
3.2 Global Circulating Tumor Cells Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Circulating Tumor Cells Revenue
3.4 Global Circulating Tumor Cells Market Concentration Ratio
3.4.1 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Circulating Tumor Cells Revenue in 2022
3.5 Circulating Tumor Cells Key Players Head office and Area Served
3.6 Key Players Circulating Tumor Cells Product Solution and Service
3.7 Date of Enter into Circulating Tumor Cells Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Circulating Tumor Cells Breakdown Data by Type
4.1 Global Circulating Tumor Cells Historic Market Size by Type (2018-2023)
4.2 Global Circulating Tumor Cells Forecasted Market Size by Type (2024-2029)
5 Circulating Tumor Cells Breakdown Data by Application
5.1 Global Circulating Tumor Cells Historic Market Size by Application (2018-2023)
5.2 Global Circulating Tumor Cells Forecasted Market Size by Application (2024-2029)
6 United States Circulating Tumor Cells Market Facts & Figures
6.1 United States Circulating Tumor Cells Revenue by Company (2018-2023)
6.2 United States Circulating Tumor Cells Market Size by Type
6.2.1 United States Circulating Tumor Cells Market Size by Type (2018-2023)
6.2.2 United States Circulating Tumor Cells Market Size by Type (2024-2029)
6.2.3 United States Circulating Tumor Cells Market Share by Type (2018-2029)
6.3 United States Circulating Tumor Cells Market Size by Application
6.3.1 United States Circulating Tumor Cells Market Size by Application (2018-2023)
6.3.2 United States Circulating Tumor Cells Market Size by Application (2024-2029)
6.3.3 United States Circulating Tumor Cells Market Share by Application (2018-2029)
7 Europe Circulating Tumor Cells Market Facts & Figures
7.1 Europe Circulating Tumor Cells Revenue by Company (2018-2023)
7.2 Europe Circulating Tumor Cells Market Size by Type
7.2.1 Europe Circulating Tumor Cells Market Size by Type (2018-2023)
7.2.2 Europe Circulating Tumor Cells Market Size by Type (2024-2029)
7.2.3 Europe Circulating Tumor Cells Market Share by Type (2018-2029)
7.3 Europe Circulating Tumor Cells Market Size by Application
7.3.1 Europe Circulating Tumor Cells Market Size by Application (2018-2023)
7.3.2 Europe Circulating Tumor Cells Market Size by Application (2024-2029)
7.3.3 Europe Circulating Tumor Cells Market Share by Application (2018-2029)
8 China Circulating Tumor Cells Market Facts & Figures
8.1 China Circulating Tumor Cells Revenue by Company (2018-2023)
8.2 China Circulating Tumor Cells Market Size by Type
8.2.1 China Circulating Tumor Cells Market Size by Type (2018-2023)
8.2.2 China Circulating Tumor Cells Market Size by Type (2024-2029)
8.2.3 China Circulating Tumor Cells Market Share by Type (2018-2029)
8.3 China Circulating Tumor Cells Market Size by Application
8.3.1 China Circulating Tumor Cells Market Size by Application (2018-2023)
8.3.2 China Circulating Tumor Cells Market Size by Application (2024-2029)
8.3.3 China Circulating Tumor Cells Market Share by Application (2018-2029)
9 Japan Circulating Tumor Cells Market Facts & Figures
9.1 Japan Circulating Tumor Cells Revenue by Company (2018-2023)
9.2 Japan Circulating Tumor Cells Market Size by Type
9.2.1 Japan Circulating Tumor Cells Market Size by Type (2018-2023)
9.2.2 Japan Circulating Tumor Cells Market Size by Type (2024-2029)
9.2.3 Japan Circulating Tumor Cells Market Share by Type (2018-2029)
9.3 Japan Circulating Tumor Cells Market Size by Application
9.3.1 Japan Circulating Tumor Cells Market Size by Application (2018-2023)
9.3.2 Japan Circulating Tumor Cells Market Size by Application (2024-2029)
9.3.3 Japan Circulating Tumor Cells Market Share by Application (2018-2029)
10 Southeast Asia Circulating Tumor Cells Market Facts & Figures
10.1 Southeast Asia Circulating Tumor Cells Revenue by Company (2018-2023)
10.2 Southeast Asia Circulating Tumor Cells Market Size by Type
10.2.1 Southeast Asia Circulating Tumor Cells Market Size by Type (2018-2023)
10.2.2 Southeast Asia Circulating Tumor Cells Market Size by Type (2024-2029)
10.2.3 Southeast Asia Circulating Tumor Cells Market Share by Type (2018-2029)
10.3 Southeast Asia Circulating Tumor Cells Market Size by Application
10.3.1 Southeast Asia Circulating Tumor Cells Market Size by Application (2018-2023)
10.3.2 Southeast Asia Circulating Tumor Cells Market Size by Application (2024-2029)
10.3.3 Southeast Asia Circulating Tumor Cells Market Share by Application (2018-2029)
11 India Circulating Tumor Cells Market Facts & Figures
11.1 India Circulating Tumor Cells Revenue by Company (2018-2023)
11.2 India Circulating Tumor Cells Market Size by Type
11.2.1 India Circulating Tumor Cells Market Size by Type (2018-2023)
11.2.2 India Circulating Tumor Cells Market Size by Type (2024-2029)
11.2.3 India Circulating Tumor Cells Market Share by Type (2018-2029)
11.3 India Circulating Tumor Cells Market Size by Application
11.3.1 India Circulating Tumor Cells Market Size by Application (2018-2023)
11.3.2 India Circulating Tumor Cells Market Size by Application (2024-2029)
11.3.3 India Circulating Tumor Cells Market Share by Application (2018-2029)
12 Key Players Profiles
12.1 Menarini-Silicon Biosystems
12.1.1 Menarini-Silicon Biosystems Company Details
12.1.2 Menarini-Silicon Biosystems Business Overview
12.1.3 Menarini-Silicon Biosystems Circulating Tumor Cells Introduction
12.1.4 Menarini-Silicon Biosystems Revenue in Circulating Tumor Cells Business (2018-2023)
12.1.5 Menarini-Silicon Biosystems Recent Development
12.2 Qiagen (Adnagen)
12.2.1 Qiagen (Adnagen) Company Details
12.2.2 Qiagen (Adnagen) Business Overview
12.2.3 Qiagen (Adnagen) Circulating Tumor Cells Introduction
12.2.4 Qiagen (Adnagen) Revenue in Circulating Tumor Cells Business (2018-2023)
12.2.5 Qiagen (Adnagen) Recent Development
12.3 Advanced Cell Diagnostics
12.3.1 Advanced Cell Diagnostics Company Details
12.3.2 Advanced Cell Diagnostics Business Overview
12.3.3 Advanced Cell Diagnostics Circulating Tumor Cells Introduction
12.3.4 Advanced Cell Diagnostics Revenue in Circulating Tumor Cells Business (2018-2023)
12.3.5 Advanced Cell Diagnostics Recent Development
12.4 ApoCell
12.4.1 ApoCell Company Details
12.4.2 ApoCell Business Overview
12.4.3 ApoCell Circulating Tumor Cells Introduction
12.4.4 ApoCell Revenue in Circulating Tumor Cells Business (2018-2023)
12.4.5 ApoCell Recent Development
12.5 Epic Sciences
12.5.1 Epic Sciences Company Details
12.5.2 Epic Sciences Business Overview
12.5.3 Epic Sciences Circulating Tumor Cells Introduction
12.5.4 Epic Sciences Revenue in Circulating Tumor Cells Business (2018-2023)
12.5.5 Epic Sciences Recent Development
12.6 Greiner Bio-one GmbH
12.6.1 Greiner Bio-one GmbH Company Details
12.6.2 Greiner Bio-one GmbH Business Overview
12.6.3 Greiner Bio-one GmbH Circulating Tumor Cells Introduction
12.6.4 Greiner Bio-one GmbH Revenue in Circulating Tumor Cells Business (2018-2023)
12.6.5 Greiner Bio-one GmbH Recent Development
12.7 Cynvenio
12.7.1 Cynvenio Company Details
12.7.2 Cynvenio Business Overview
12.7.3 Cynvenio Circulating Tumor Cells Introduction
12.7.4 Cynvenio Revenue in Circulating Tumor Cells Business (2018-2023)
12.7.5 Cynvenio Recent Development
12.8 SurExamBio-Tech
12.8.1 SurExamBio-Tech Company Details
12.8.2 SurExamBio-Tech Business Overview
12.8.3 SurExamBio-Tech Circulating Tumor Cells Introduction
12.8.4 SurExamBio-Tech Revenue in Circulating Tumor Cells Business (2018-2023)
12.8.5 SurExamBio-Tech Recent Development
12.9 Fluxion Biosciences
12.9.1 Fluxion Biosciences Company Details
12.9.2 Fluxion Biosciences Business Overview
12.9.3 Fluxion Biosciences Circulating Tumor Cells Introduction
12.9.4 Fluxion Biosciences Revenue in Circulating Tumor Cells Business (2018-2023)
12.9.5 Fluxion Biosciences Recent Development
12.10 Ikonisys
12.10.1 Ikonisys Company Details
12.10.2 Ikonisys Business Overview
12.10.3 Ikonisys Circulating Tumor Cells Introduction
12.10.4 Ikonisys Revenue in Circulating Tumor Cells Business (2018-2023)
12.10.5 Ikonisys Recent Development
12.11 Hangzhou Watson Biotech
12.11.1 Hangzhou Watson Biotech Company Details
12.11.2 Hangzhou Watson Biotech Business Overview
12.11.3 Hangzhou Watson Biotech Circulating Tumor Cells Introduction
12.11.4 Hangzhou Watson Biotech Revenue in Circulating Tumor Cells Business (2018-2023)
12.11.5 Hangzhou Watson Biotech Recent Development
12.12 Biocept
12.12.1 Biocept Company Details
12.12.2 Biocept Business Overview
12.12.3 Biocept Circulating Tumor Cells Introduction
12.12.4 Biocept Revenue in Circulating Tumor Cells Business (2018-2023)
12.12.5 Biocept Recent Development
12.13 CytoTrack
12.13.1 CytoTrack Company Details
12.13.2 CytoTrack Business Overview
12.13.3 CytoTrack Circulating Tumor Cells Introduction
12.13.4 CytoTrack Revenue in Circulating Tumor Cells Business (2018-2023)
12.13.5 CytoTrack Recent Development
12.14 Guangzhou Wondfo Biotech
12.14.1 Guangzhou Wondfo Biotech Company Details
12.14.2 Guangzhou Wondfo Biotech Business Overview
12.14.3 Guangzhou Wondfo Biotech Circulating Tumor Cells Introduction
12.14.4 Guangzhou Wondfo Biotech Revenue in Circulating Tumor Cells Business (2018-2023)
12.14.5 Guangzhou Wondfo Biotech Recent Development
12.15 Celsee
12.15.1 Celsee Company Details
12.15.2 Celsee Business Overview
12.15.3 Celsee Circulating Tumor Cells Introduction
12.15.4 Celsee Revenue in Circulating Tumor Cells Business (2018-2023)
12.15.5 Celsee Recent Development
12.16 Clearbridge Biomedics
12.16.1 Clearbridge Biomedics Company Details
12.16.2 Clearbridge Biomedics Business Overview
12.16.3 Clearbridge Biomedics Circulating Tumor Cells Introduction
12.16.4 Clearbridge Biomedics Revenue in Circulating Tumor Cells Business (2018-2023)
12.16.5 Clearbridge Biomedics Recent Development
12.17 ANGLE plc
12.17.1 ANGLE plc Company Details
12.17.2 ANGLE plc Business Overview
12.17.3 ANGLE plc Circulating Tumor Cells Introduction
12.17.4 ANGLE plc Revenue in Circulating Tumor Cells Business (2018-2023)
12.17.5 ANGLE plc Recent Development
13 Market Dynamics
13.1 Circulating Tumor Cells Industry Trends
13.2 Circulating Tumor Cells Market Drivers
13.3 Circulating Tumor Cells Market Challenges
13.4 Circulating Tumor Cells Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author List
15.3 Disclaimer

Companies Mentioned:

Menarini-Silicon Biosystems
Qiagen (Adnagen)
Advanced Cell Diagnostics
ApoCell
Epic Sciences
Greiner Bio-one GmbH
Cynvenio
SurExamBio-Tech
Fluxion Biosciences
Ikonisys
Hangzhou Watson Biotech
Biocept
CytoTrack
Guangzhou Wondfo Biotech
Celsee
Clearbridge Biomedics
ANGLE plc

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂